These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 8972009

  • 1. More effective suppression of hemostatic system activation in patients undergoing cardiac surgery by heparin dosing based on heparin blood concentrations rather than ACT.
    Despotis GJ, Joist JH, Hogue CW, Alsoufiev A, Joiner-Maier D, Santoro SA, Spitznagel E, Weitz JI, Goodnough LT.
    Thromb Haemost; 1996 Dec; 76(6):902-8. PubMed ID: 8972009
    [Abstract] [Full Text] [Related]

  • 2. A comparison of heparin management strategies in infants undergoing cardiopulmonary bypass.
    Guzzetta NA, Bajaj T, Fazlollah T, Szlam F, Wilson E, Kaiser A, Tosone SR, Miller BE.
    Anesth Analg; 2008 Feb; 106(2):419-25, table of contents. PubMed ID: 18227295
    [Abstract] [Full Text] [Related]

  • 3. Correlations between activated clotting time values and heparin concentration measurements in young infants undergoing cardiopulmonary bypass.
    Guzzetta NA, Monitz HG, Fernandez JD, Fazlollah TM, Knezevic A, Miller BE.
    Anesth Analg; 2010 Jul; 111(1):173-9. PubMed ID: 20519414
    [Abstract] [Full Text] [Related]

  • 4. Anticoagulation and anticoagulation reversal with cardiac surgery involving cardiopulmonary bypass: an update.
    Despotis GJ, Joist JH.
    J Cardiothorac Vasc Anesth; 1999 Aug; 13(4 Suppl 1):18-29; discussion 36-7. PubMed ID: 10468245
    [Abstract] [Full Text] [Related]

  • 5. A comparison of activated coagulation time-based techniques for anticoagulation during cardiac surgery with cardiopulmonary bypass.
    Slight RD, Buell R, Nzewi OC, McClelland DB, Mankad PS.
    J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):47-52. PubMed ID: 18249330
    [Abstract] [Full Text] [Related]

  • 6. Monitoring activated clotting time for combined heparin and aprotinin application: in vivo evaluation of a new aprotinin-insensitive test using Sonoclot.
    Ganter MT, Monn A, Tavakoli R, Genoni M, Klaghofer R, Furrer L, Honegger H, Hofer CK.
    Eur J Cardiothorac Surg; 2006 Aug; 30(2):278-84. PubMed ID: 16828293
    [Abstract] [Full Text] [Related]

  • 7. Kaolin-based activated coagulation time measured by sonoclot in patients undergoing cardiopulmonary bypass.
    Ganter MT, Monn A, Tavakoli R, Klaghofer R, Zollinger A, Hofer CK.
    J Cardiothorac Vasc Anesth; 2007 Aug; 21(4):524-8. PubMed ID: 17678778
    [Abstract] [Full Text] [Related]

  • 8. Antithrombin III during cardiac surgery: effect on response of activated clotting time to heparin and relationship to markers of hemostatic activation.
    Despotis GJ, Levine V, Joist JH, Joiner-Maier D, Spitznagel E.
    Anesth Analg; 1997 Sep; 85(3):498-506. PubMed ID: 9296400
    [Abstract] [Full Text] [Related]

  • 9. Heparin dosing and monitoring for cardiopulmonary bypass. A comparison of techniques with measurement of subclinical plasma coagulation.
    Gravlee GP, Haddon WS, Rothberger HK, Mills SA, Rogers AT, Bean VE, Buss DH, Prough DS, Cordell AR.
    J Thorac Cardiovasc Surg; 1990 Mar; 99(3):518-27. PubMed ID: 2308370
    [Abstract] [Full Text] [Related]

  • 10. Monitoring high-dose heparinization during cardiopulmonary by-pass--a comparison between prothrombinase-induced clotting time (PiCT) and two chromogenic anti-factor Xa activity assays.
    Raivio P, Kuitunen A, Petäjä J, Ilveskero S, Lassila R.
    Thromb Haemost; 2008 Feb; 99(2):427-34. PubMed ID: 18278195
    [Abstract] [Full Text] [Related]

  • 11. In vivo and in vitro evaluation of the heparin management test versus the activated coagulation time for monitoring anticoagulation level in aprotinin-treated patients during cardiac surgery.
    Kim YS, Murkin JM, Adams SJ.
    Heart Surg Forum; 2004 Feb; 7(6):E599-604. PubMed ID: 15769695
    [Abstract] [Full Text] [Related]

  • 12. The effects of MDCO-2010, a serine protease inhibitor, on activated clotting time in blood obtained from volunteers and cardiac surgical patients.
    Kim H, Szlam F, Tanaka KA, van de Locht A, Ogawa S, Levy JH.
    Anesth Analg; 2012 Aug; 115(2):244-52. PubMed ID: 22584552
    [Abstract] [Full Text] [Related]

  • 13. The treatment of heparin resistance with Antithrombin III in cardiac surgery.
    Kanbak M.
    Can J Anaesth; 1999 Jun; 46(6):581-5. PubMed ID: 10391608
    [Abstract] [Full Text] [Related]

  • 14. Coagulation and fibrinolysis system in aortic surgery under deep hypothermic circulatory arrest with aprotinin: the importance of adequate heparinization.
    Okita Y, Takamoto S, Ando M, Morota T, Yamaki F, Matsukawa R, Kawashima Y.
    Circulation; 1997 Nov 04; 96(9 Suppl):II-376-81. PubMed ID: 9386127
    [Abstract] [Full Text] [Related]

  • 15. Heparin management during cardiac surgery with respect to various blood-conservation techniques.
    Boldt J, Zickmann B, Herold C, Scholz S, Dapper F, Hempelmann G.
    Surgery; 1992 Mar 04; 111(3):260-5. PubMed ID: 1542853
    [Abstract] [Full Text] [Related]

  • 16. Detection of protamine and heparin after termination of cardiopulmonary bypass by thrombelastometry (ROTEM): results of a pilot study.
    Mittermayr M, Velik-Salchner C, Stalzer B, Margreiter J, Klingler A, Streif W, Fries D, Innerhofer P.
    Anesth Analg; 2009 Mar 04; 108(3):743-50. PubMed ID: 19224778
    [Abstract] [Full Text] [Related]

  • 17. Coagulation and fibrinolytic profile of paediatric patients undergoing cardiopulmonary bypass.
    Chan AK, Leaker M, Burrows FA, Williams WG, Gruenwald CE, Whyte L, Adams M, Brooker LA, Adams H, Mitchell L, Andrew M.
    Thromb Haemost; 1997 Feb 04; 77(2):270-7. PubMed ID: 9157580
    [Abstract] [Full Text] [Related]

  • 18. The role of the activated clotting time in heparin administration and neutralization for cardiopulmonary bypass.
    Esposito RA, Culliford AT, Colvin SB, Thomas SJ, Lackner H, Spencer FC.
    J Thorac Cardiovasc Surg; 1983 Feb 04; 85(2):174-85. PubMed ID: 6823136
    [Abstract] [Full Text] [Related]

  • 19. Hemostasis changes during cardiopulmonary bypass surgery.
    Mammen EF, Koets MH, Washington BC, Wolk LW, Brown JM, Burdick M, Selik NR, Wilson RF.
    Semin Thromb Hemost; 1985 Jul 04; 11(3):281-92. PubMed ID: 4048952
    [Abstract] [Full Text] [Related]

  • 20. Thrombin generation during cardiac surgery: is heparin the ideal anticoagulant?
    Brister SJ, Ofosu FA, Buchanan MR.
    Thromb Haemost; 1993 Aug 02; 70(2):259-62. PubMed ID: 8236131
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.